{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T23:19:20Z","timestamp":1785539960769,"version":"3.56.0"},"reference-count":38,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2017,11,15]],"date-time":"2017-11-15T00:00:00Z","timestamp":1510704000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000272","name":"National Institute for Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000272","name":"National Institute for Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008721","name":"University College London Hospitals NHS Foundation Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008721","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bjui-journals.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["BJU International"],"published-print":{"date-parts":[[2018,3]]},"abstract":"<jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>\n                      To evaluate the occurrence of severe urinary complications within 2 years of surgery in men undergoing either robot\u2010assisted radical prostatectomy (\n                      <jats:styled-content style=\"fixed-case\">RARP<\/jats:styled-content>\n                      ), laparoscopic radical prostatectomy (\n                      <jats:styled-content style=\"fixed-case\">LRP<\/jats:styled-content>\n                      ) or retropubic open radical prostatectomy (\n                      <jats:styled-content style=\"fixed-case\">ORP<\/jats:styled-content>\n                      ).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Patients and Methods<\/jats:title>\n                    <jats:p>\n                      We conducted a population\u2010based cohort study in men who underwent\n                      <jats:styled-content style=\"fixed-case\">RARP<\/jats:styled-content>\n                      (\n                      <jats:italic>n<\/jats:italic>\n                      = 4 947),\n                      <jats:styled-content style=\"fixed-case\">LRP<\/jats:styled-content>\n                      (\n                      <jats:italic>n<\/jats:italic>\n                      = 5 479) or\n                      <jats:styled-content style=\"fixed-case\">ORP<\/jats:styled-content>\n                      (\n                      <jats:italic>n<\/jats:italic>\n                      = 6 873) between 2008 and 2012 in the English National Health Service (\n                      <jats:styled-content style=\"fixed-case\">NHS<\/jats:styled-content>\n                      ) using national cancer registry records linked to Hospital Episodes Statistics, an administrative database of admissions to\n                      <jats:styled-content style=\"fixed-case\">NHS<\/jats:styled-content>\n                      hospitals. We identified the occurrence of any severe urinary or severe stricture\u2010related complication within 2 years of surgery using a validated tool. Multi\u2010level regression modelling was used to determine the association between the type of surgery and occurrence of complications, with adjustment for patient and surgical factors.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Men undergoing\n                      <jats:styled-content style=\"fixed-case\">RARP<\/jats:styled-content>\n                      were least likely to experience any urinary complication (10.5%) or a stricture\u2010related complication (3.3%) compared with those who had\n                      <jats:styled-content style=\"fixed-case\">LRP<\/jats:styled-content>\n                      (15.8% any or 5.7% stricture\u2010related) or\n                      <jats:styled-content style=\"fixed-case\">ORP<\/jats:styled-content>\n                      (19.1% any or 6.9% stricture\u2010related). The impact of the type of surgery on the occurrence of any urinary or stricture\u2010related complications remained statistically significant after adjustment for patient and surgical factors (\n                      <jats:italic>P<\/jats:italic>\n                      &lt; 0.01).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>\n                      Men who underwent\n                      <jats:styled-content style=\"fixed-case\">RARP<\/jats:styled-content>\n                      had the lowest risk of developing severe urinary complications within 2 years of surgery.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1111\/bju.14054","type":"journal-article","created":{"date-parts":[[2017,10,15]],"date-time":"2017-10-15T10:52:36Z","timestamp":1508064756000},"page":"445-452","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["National cohort study comparing severe medium\u2010term urinary complications after robot\u2010assisted vs laparoscopic vs retropubic open radical prostatectomy"],"prefix":"10.1111","volume":"121","author":[{"given":"Arunan","family":"Sujenthiran","sequence":"first","affiliation":[{"name":"Clinical Effectiveness Unit Royal College of Surgeons of England London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Nossiter","sequence":"additional","affiliation":[{"name":"Clinical Effectiveness Unit Royal College of Surgeons of England London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Parry","sequence":"additional","affiliation":[{"name":"Clinical Effectiveness Unit Royal College of Surgeons of England London UK"},{"name":"Department of Health Services Research and Policy London School of Hygiene and Tropical Medicine London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan C.","family":"Charman","sequence":"additional","affiliation":[{"name":"Clinical Effectiveness Unit Royal College of Surgeons of England London UK"},{"name":"Department of Health Services Research and Policy London School of Hygiene and Tropical Medicine London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ajay","family":"Aggarwal","sequence":"additional","affiliation":[{"name":"Department of Health Services Research and Policy London School of Hygiene and Tropical Medicine London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather","family":"Payne","sequence":"additional","affiliation":[{"name":"Department of Oncology University College London Hospitals London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prokar","family":"Dasgupta","sequence":"additional","affiliation":[{"name":"MRC Centre for Transplantation King's College London London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noel W.","family":"Clarke","sequence":"additional","affiliation":[{"name":"Department of Urology Christie and Salford Royal NHS Foundation Trusts Manchester UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"van der Meulen","sequence":"additional","affiliation":[{"name":"Department of Health Services Research and Policy London School of Hygiene and Tropical Medicine London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Cathcart","sequence":"additional","affiliation":[{"name":"Department of Urology Guy's and St Thomas' NHS Foundation Trust London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2017,11,15]]},"reference":[{"key":"e_1_2_7_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2012.02.029"},{"key":"e_1_2_7_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2009.01.036"},{"key":"e_1_2_7_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2012.05.044"},{"key":"e_1_2_7_5_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2013.53.5096"},{"key":"e_1_2_7_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2011.12.027"},{"key":"e_1_2_7_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2016.01.044"},{"key":"e_1_2_7_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(16)30592-X"},{"key":"e_1_2_7_9_1","doi-asserted-by":"publisher","DOI":"10.1111\/bju.13770"},{"key":"e_1_2_7_10_1","unstructured":"ICD\u201010 International Classification of Diseases(10th revised edition). Available at:https:\/\/digital.nhs.uk\/article\/1117\/Clinical-Classifications. Accessed December 2016"},{"key":"e_1_2_7_11_1","unstructured":"English Cancer Registry Data. Available at:http:\/\/www.ncin.org.uk\/collecting_and_using_data\/national_cancer_data_repository. Accessed December 2016"},{"key":"e_1_2_7_12_1","unstructured":"OPCS\u20104 classification of interventions and procedures. Available at:https:\/\/digital.nhs.uk\/article\/1117\/Clinical-Classifications. Accessed December 2016"},{"key":"e_1_2_7_13_1","unstructured":"Hospital Episode Statistics. Available at:http:\/\/www.hesonline.nhs.uk. Accessed December 2016"},{"key":"e_1_2_7_14_1","volume-title":"The English Indices of Deprivation","author":"Noble MD","year":"2007"},{"key":"e_1_2_7_15_1","doi-asserted-by":"publisher","DOI":"10.1002\/bjs.6930"},{"key":"e_1_2_7_16_1","article-title":"Systematic review of the volume & outcome relationship for radical prostatectomy: a 2017 update","author":"Leow JJ","year":"2017","journal-title":"Eur Urol Focus"},{"key":"e_1_2_7_17_1","unstructured":"NHS England; Clinical commissioning policy: Robotic\u2010assisted surgical procedures for prostate cancer 2015. Available at:https:\/\/www.england.nhs.uk\/commissioning\/wp-content\/uploads\/sites\/12\/2015\/10\/b14pa-rbtic-asstd-srgry-prostate-cancer-oct15.pdf. Accessed December 2016"},{"key":"e_1_2_7_18_1","unstructured":"Common Terminology Criteria for Adverse Events (CTCAE).National Institute of Health. National Cancer Institute. Available at:https:\/\/www.eortc.be\/services\/doc\/ctc\/CTCAE_4.03_2010-06-14_QuickReference_5x7.pdf. Accessed December 2016"},{"key":"e_1_2_7_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2011.10.033"},{"key":"e_1_2_7_20_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2003.05.169"},{"key":"e_1_2_7_21_1","doi-asserted-by":"publisher","DOI":"10.5489\/cuaj.3214"},{"key":"e_1_2_7_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.urolonc.2009.03.001"},{"key":"e_1_2_7_23_1","doi-asserted-by":"publisher","DOI":"10.1093\/pubmed\/fdr054"},{"key":"e_1_2_7_24_1","unstructured":"National Prostate Cancer Audit (NPCA) Team (Sujenthiran A Nossiter J et al.). NPCA 3rd Annual Report 2016"},{"key":"e_1_2_7_25_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2009.1451"},{"key":"e_1_2_7_26_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464-410X.2008.08012.x"},{"key":"e_1_2_7_27_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464-410X.2005.05563.x"},{"key":"e_1_2_7_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5347(05)00156-4"},{"key":"e_1_2_7_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.urology.2008.03.067"},{"key":"e_1_2_7_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2014.01.039"},{"key":"e_1_2_7_31_1","doi-asserted-by":"publisher","DOI":"10.1002\/bjs.9847"},{"key":"e_1_2_7_32_1","doi-asserted-by":"publisher","DOI":"10.1136\/hrt.2008.149849"},{"key":"e_1_2_7_33_1","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/1481727"},{"key":"e_1_2_7_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5347(01)62202-X"},{"key":"e_1_2_7_35_1","doi-asserted-by":"publisher","DOI":"10.1159\/000075267"},{"key":"e_1_2_7_36_1","doi-asserted-by":"publisher","DOI":"10.1002\/jso.24687"},{"key":"e_1_2_7_37_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464-410X.2009.08751.x"},{"key":"e_1_2_7_38_1","unstructured":"National Prostate Cancer Audit (NPCA) Team (Sujenthiran A Nossiter J et al.). NPCA 2nd Annual Report 2015 \u2013 Further analysis of existing clinical data and preliminary results from the NPCA Prospective Audit"},{"key":"e_1_2_7_39_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2017.03.028"}],"container-title":["BJU International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fbju.14054","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/bjui-journals.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/bju.14054","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T14:33:12Z","timestamp":1761748392000},"score":1,"resource":{"primary":{"URL":"https:\/\/bjui-journals.onlinelibrary.wiley.com\/doi\/10.1111\/bju.14054"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11,15]]},"references-count":38,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,3]]}},"alternative-id":["10.1111\/bju.14054"],"URL":"https:\/\/doi.org\/10.1111\/bju.14054","archive":["Portico"],"relation":{},"ISSN":["1464-4096","1464-410X"],"issn-type":[{"value":"1464-4096","type":"print"},{"value":"1464-410X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,11,15]]},"assertion":[{"value":"2017-11-15","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}